Fibrosarcoma

P2/3, N=140, Completed, National Cancer Institute (NCI) | Active, not recruiting --> Completed | Trial completion date: Dec 2026 --> Mar 2026

A deep-seated soft-tissue mass displaying heterogeneous T2 signal with hypointense collagenous areas and progressive enhancement should raise suspicion for sclerosing epithelioid fibrosarcoma, especially in atypical locations such as the iliac fossa. Definitive diagnosis requires histopathology and immunohistochemistry (MUC4), while long-term follow-up is essential to monitor late recurrence or metastasis.

Cucurbitacin B-induced TNF-R1 shedding was attenuated by TNF-α protease inhibitor 2 and the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) kinase (MEK) inhibitor U0126, but not by the p38 MAPK inhibitor SB203580 or the c-Jun N-terminal kinase (JNK) inhibitor SP600125. Consistent with these results, cucurbitacin B promoted the rapid phosphorylation of rapidly accelerated fibrosarcoma 1 (RAF1) and ERK, but exerted minimal effects on the phosphorylation of p38 MAPK and JNK. Collectively, these results demonstrate that cucurbitacin B selectively activated the RAF1-MEK-ERK pathway, which was essential for TNF-R1 ectodomain shedding.

In the G. mellonella model, berberine and curcumin did not differ significantly from the PBS or DMSO controls, whereas CAPE, CurE, and particularly biochanin A produced significantly greater larval mortality. The G. mellonella assay should be regarded only as a preliminary acute toxicity screen, and further in vivo studies in mammalian models are required to clarify mechanisms and clinical relevance.

This study provides new mechanistic insight into the neuroprotective effects of P. orientalis on rMc-1 under diabetic stress. EAPO could attenuate high-glucose-induced neuronal toxicity in rMc-1 by modulating the AKT1/mTOR and Raf-1/MEK1/2 pathways through AMPK activation.

We suggest that the NRL-mediated gene regulatory network includes transient and stable but context-dependent protein-protein interactions, which control quantitatively precise gene expression patterns in mature rod photoreceptors. Our findings suggest therapeutic potential for retinopathies involving photoreceptor dysfunction through targeted gene expression modulation.

Reactive astrocytes preferentially phagocytose GABAergic synapses in BCP, thereby contributing to synaptic imbalance and central sensitization. This process is associated with downregulation of astrocytic NRCAM. Restoring astrocytic NRCAM alleviates BCP by suppressing excessive astrocyte-mediated phagocytosis of GABAergic synapses. These findings identify astrocytic NRCAM-dependent synaptic phagocytosis as an unrecognized mechanism underlying BCP and as a potential therapeutic target.

Further, through TEM imaging and upregulation of caspase-3 we confirmed PEG-GNR induced apoptosis. Our study reports that PEG-GNRs selectively inhibit the growth of cancer cells, rarely causing toxicity to normal cells, as supported by both comet and micronuclei assay.

RAF/BRAF-driven mesenchymal tumours possess a broader clinicopathologic spectrum than traditionally recognised, frequently affecting adults and deep/visceral sites. Their inherently variable immunophenotypes and the presence of high-grade morphologic features do not strictly predict an aggressive clinical trajectory. Comprehensive molecular profiling is essential to refine diagnostic criteria, accurately identify these neoplasms, and elucidate the genomic events associated with tumour progression.

The successful management with combined surgical and radiation therapy demonstrates the need for individualized treatment approaches in complex anatomical locations. Four-year remission demonstrated the efficacy of comprehensive multimodal therapy in preventing local recurrence in FS-DFSP.

Functionally, MAFF-mediated repression of CPT2 diminishes fatty acid oxidation and enhances tumor invasion, underscoring a dual role whereby MAFF drives tumor progression yet primes cells for ferroptotic death. Collectively, our study identifies MAFF as a transcriptional switch linking iron homeostasis and lipid metabolism to ferroptotic vulnerability, highlighting its potential as a biomarker and therapeutic target in basal-like breast cancer.

In addition, MAFK overexpression reversed the suppressive effect of AREG knockdown on the proliferation of A549 and PC-9 cells. Collectively, MAFK enabled NSCLC cells to escape DOX-induced senescence by upregulating AREG and facilitated cell proliferation upon DOX treatment.